These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21552194

  • 1. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2011; 32(2):133-40. PubMed ID: 21552194
    [Abstract] [Full Text] [Related]

  • 2. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
    Maes M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):784-94. PubMed ID: 20609377
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M, Twisk FN, Ringel K.
    Psychother Psychosom; 2012 Apr 29; 81(5):286-95. PubMed ID: 22832503
    [Abstract] [Full Text] [Related]

  • 4. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2009 Apr 29; 30(4):462-9. PubMed ID: 20010493
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M, Leunis JC.
    Neuro Endocrinol Lett; 2014 Apr 29; 35(7):577-85. PubMed ID: 25617880
    [Abstract] [Full Text] [Related]

  • 6. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2009 Apr 29; 30(4):470-6. PubMed ID: 20010505
    [Abstract] [Full Text] [Related]

  • 7. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M, Twisk FN.
    Neuro Endocrinol Lett; 2009 Apr 29; 30(6):677-93. PubMed ID: 20038921
    [Abstract] [Full Text] [Related]

  • 8. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M, Twisk FN, Johnson C.
    Psychiatry Res; 2012 Dec 30; 200(2-3):754-60. PubMed ID: 22521895
    [Abstract] [Full Text] [Related]

  • 9. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
    Maes M.
    Neuro Endocrinol Lett; 2015 Dec 30; 36(4):320-9. PubMed ID: 26454487
    [Abstract] [Full Text] [Related]

  • 10. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.
    J Affect Disord; 2013 Sep 05; 150(2):223-30. PubMed ID: 23664637
    [Abstract] [Full Text] [Related]

  • 11. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
    Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Neuro Endocrinol Lett; 2009 Sep 05; 30(6):715-22. PubMed ID: 20035260
    [Abstract] [Full Text] [Related]

  • 12. "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression.
    Maes M.
    Neuro Endocrinol Lett; 2009 Sep 05; 30(5):564-73. PubMed ID: 20035251
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
    Med Sci Monit; 2011 Apr 05; 17(4):SC11-5. PubMed ID: 21455120
    [Abstract] [Full Text] [Related]

  • 14. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
    Daniels J, Brigden A, Kacorova A.
    Psychol Psychother; 2017 Sep 05; 90(3):502-509. PubMed ID: 28244209
    [Abstract] [Full Text] [Related]

  • 15. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
    Maes M, Mihaylova I, Leunis JC.
    Neuro Endocrinol Lett; 2007 Dec 05; 28(6):861-7. PubMed ID: 18063934
    [Abstract] [Full Text] [Related]

  • 16. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
    Maes M, Mihaylova I, Kubera M, Bosmans E.
    Neuro Endocrinol Lett; 2007 Aug 05; 28(4):463-9. PubMed ID: 17693978
    [Abstract] [Full Text] [Related]

  • 17. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
    Maes M, Mihaylova I, Kubera M, Leunis JC, Twisk FN, Geffard M.
    Metab Brain Dis; 2012 Dec 05; 27(4):415-23. PubMed ID: 22614823
    [Abstract] [Full Text] [Related]

  • 18. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF, Hall DL, Jutagir DR, Lattie EG, Ironson GH, Wohlgemuth W, Nunez MV, Garcia L, Czaja SJ, Perdomo DM, Fletcher MA, Klimas N, Antoni MH.
    J Neuroimmunol; 2017 Feb 15; 303():43-50. PubMed ID: 28038892
    [Abstract] [Full Text] [Related]

  • 19. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
    Maes M, Galecki P, Chang YS, Berk M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):676-92. PubMed ID: 20471444
    [Abstract] [Full Text] [Related]

  • 20. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS.
    Maes M, Mihaylova I, Kubera M, Leunis JC.
    Neuro Endocrinol Lett; 2008 Jun 29; 29(3):313-9. PubMed ID: 18580855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.